A new model for patient access and adherence services is emerging that centers on Hub capabilities within the 'middle-market' between traditional, retail drugs and high priced specialty drugs – Hub-Lite™. Triplefin's Hub-Lite™ reflects a highly integrated service approach that supports brands that require similar, high touch services like specialty drugs require, including prior authorization and case management, but without the high price tag and elaborate coordination efforts.
 
Using a platform of automated, online tools, brands can build a solution for reimbursement-related services, such as benefit verification, prior authorization and co-pay card activation and tie to alternative patient engagement activities that accelerate speed-to-therapy and decrease prescription abandonment on first fill and beyond.
 
Download Triplefin's informative article, "Remove Reimbursement Obstacles to Boost Patient Access to Medications," for a look into the new offering of Hub-Lite™.